ECL
57
18
ROST
49
8
HAS
60
2
NVDA
60
3
ED
48
9
AON
45
-2
ALLE
25
2
SLB
39
-3
BMY
38
-5
HOG
35
2
URI
50
-2
SPG
43
3
TSN
40
2
DGX
61
4
EA
65
15
DTE
56
7
MHK
46
4
NRG
57
5
PCAR
39
5
ES
45
8
ECL
57
18
ROST
49
8
HAS
60
2
NVDA
60
3
ED
48
9
AON
45
-2
ALLE
25
2
SLB
39
-3
BMY
38
-5
HOG
35
2
URI
50
-2
SPG
43
3
TSN
40
2
DGX
61
4
EA
65
15
DTE
56
7
MHK
46
4
NRG
57
5
PCAR
39
5
ES
45
8
Financhill
Back

Verve Therapeutics Stock Predictions

Sleep well at night with 7 stellar stocks to buy and hold forever

Get the complete list FREE for a limited time.
Buy
55

VERV
Verve Therapeutics

Last Price:
$11.38
Seasonality Move:
61.83%

7 Day Trial

ALL ACCESS PASS

$ 7

The check disappears. Then the damage hits.

Watch the video now.

Verve Therapeutics Stock Forecast

  • Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 4.5% based on the past 4 years of stock performance.
  • Verve Therapeutics has fallen lower in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Verve Therapeutics Stock Undervalued?
    The current Verve Therapeutics [VERV] share price is $6.27. The Score for VERV is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • VERV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Verve Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 4.5% based on the past 4 years of stock performance.

Verve Therapeutics Stock Rating

Buy
55
Verve Therapeutics (VERV) is a Buy

Is Verve Therapeutics overpriced?

  • Verve Therapeutics has fallen lower in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Verve Therapeutics Stock Price History

Is VERV stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VERV is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vervetx.com

52-Week Data

52-Week High:
9.31
52-Week Low:
2.86

Prediction Charts

Market Cap:
558.9M
Price in USD:
6.27
Volume:
3M
Beta:
1.70

Technical Analysis

SMA50:
4.81
SMA100:
5.76
SMA200:
5.70
52-Wk Change:
15.68%

Stock Predictions

  • Is Verve Therapeutics stock public?
    Yes, Verve Therapeutics is a publicly traded company.
  • What is the Verve Therapeutics stock quote today?
    The Verve Therapeutics stock price is 6.27 USD today.
  • How to buy Verve Therapeutics stock online?
    You can buy Verve Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-28 4.31 4.24 4.44 4.20
May-29 4.22 4.60 4.63 3.89
May-30 4.57 4.45 4.61 4.33
Jun-2 4.54 4.80 5.10 4.50
Jun-3 4.80 4.84 5.01 4.62
Jun-4 4.87 5.29 5.43 4.85
Jun-5 5.30 5.73 6.18 5.18
Jun-6 5.85 6.20 6.58 5.77
Jun-9 6.45 6.10 6.48 5.78
Jun-10 6.20 6.39 6.54 6.01
Jun-11 6.47 6.39 6.67 6.36
Jun-12 6.29 6.32 6.39 6.10
Jun-13 5.99 6.16 6.26 5.88
Jun-16 6.25 6.27 6.41 5.94

Verve Therapeutics Earnings

Verve Therapeutics Earnings Report: Per Share Verve Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Verve Therapeutics Forecast Revenue Growth

Verve Therapeutics Stock Analysis: Historical quarterly revenues per share for Verve Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.04 per share, and a decrease next year of $0.29 per share.

* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.